Experts say cancer drugs remain in short supply, delaying life-saving treatment.

At an American Cancer Society meeting, doctors said 75% of pediatric oncology centers in the U.S. don't have enough Methotrexate.

The chemotherapy drug is used to treat a wide variety of childhood cancers.

Analysts say most of the drugs in short supply do not make a profit, so companies are reluctant to make them.